| [2022][하부] Korean clinical practice guidelines on biologics and small molecules for moderate-to-severe ulcerative colitis | |||
| Date | 2022-12-06 | ||
|---|---|---|---|
|
Korean clinical practice guidelines on biologics and
small molecules for moderate-to-severe ulcerative colitis 입니다.
아래 링크에서 확인 가능하오니 많은 열람 바랍니다.
Intest Res. 2022 May 31. doi: 10.5217/ir.2022.00007. Online ahead of print. * https://irjournal.org/journal/view.php?doi=10.5217/ir.2022.00007 |
|||